Weekly cases up 50% in Haryana, 26% in Delhi

NEW DELHI: Weekly Covid-19 cases continued to decline in the country but the fall was slowing down as the number of fresh cases inched up in Delhi, Haryana and Gujarat while a few other states showed signs of the Covid curve flattening.

However, deaths from the virus continued to fall sharply, with just around 54 fatalities recorded in the week ending Sunday (April 4-10), the lowest weekly toll in over two years since March 23-29, 2020, the week when a national lockdown was announced. Just a single Covid death was reported on Sunday (from Delhi) till late at night, with data from a few more states awaited.

Meanwhile, India reported around 7,100 new cases in the week, the lowest weekly tally in two years since April 6-12, 2020, when the number was below 5,000. Cases were down 15% as compared with the previous week, the lowest drop in weekly numbers since the third wave of the pandemic started receding in late January this year.

Delhi recorded a 26% rise in new cases during the week. The capital logged 943 cases, up from 751 in the previous seven days, reversing a declining trend in infections since the peak of the third wave. With testing numbers down, Delhi has been reporting daily positivity rates of more than 1% in the past several days. Neighbouring Haryana posted a higher rise in cases during the week. New infections were up nearly 50% from 344 in the previous week to 514.

In Gujarat, where daily cases have seen a minor spurt over the past three days, 115 fresh cases were recorded in the week. This was 89% higher than the previous week’s tally of 61. However, in all three states, the overall numbers remain low and the rise in cases could be a result of localised outbreaks.

Elsewhere, the decline in numbers was slowing down in Karnataka, which saw infections fall by 8%, Telangana (down 4%) and Maharashtra (12% decline).

Maharashtra posted 776 cases during the week as compared to 885 in the previous seven days. The state, however, reported 27 deaths from the virus during the week – half of the nationwide toll and a three-fold increase from nine fatalities logged in the previous week.

  • Related Posts

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction